Biography
My group is interested in identifying why obese individuals are at greater risk of liver injury in the setting of trauma or surgery. My long-term goal is to understand the relationship between metabolic and immunologic processes in the liver. One potential link between these underlying mechanisms could be the peptide leptin, which can profoundly modify inflammatory and metabolic pathways. The goal of this research effort is to improve understanding of the impact of leptin on acute inflammatory cascade and metabolic response during hepatic ischemia-reperfusion. This will benefit patients by improving risk-stratification of candidates for hepatic surgery and possibly lead to preventive therapies for ischemia-reperfusion injury.
Education
- 1986-93, Ludwig-Maximilians University, Munich, Germany, M.D.
- 1993-94 Intern ; City Hospital St. Georg,, University of Hamburg, Germany and Klinikum Grosshadern, Ludwig-Maximilians University, Munich, Germany
- 1996-99, University of California, San Francisco, Resident, Anesthesia
- 1994-96, Department of Anesthesiology, Northwestern University, Chicago, Illinois, Fellow, Postdoctoral Research
Board Certifications
- American Board of Anesthesiology
Clinical Expertise
Pancreas Transplantation
Liver Transplantation
Kidney Transplantation
Clinical Trials
- Intensive Insulin Therapy in Deceased Donors (NCT01140035)Related Conditions: Kidney Transplant, Transplants| Start Date: | End Date:
Program Affiliations
- Department of Anesthesia and Perioperative Care
- Department of Surgery, Division of Transplantation
- UCSF Liver Center
In the News
Research Narrative
My group is interested in identifying why obese individuals are at greater risk of liver injury in the setting of trauma or surgery. My long-term goal is to understand the relationship between metabolic and immunologic processes in the liver. One potential link between these underlying mechanisms could be the peptide leptin, which can profoundly modify inflammatory and metabolic pathways. The goal of this research effort is to improve understanding of the impact of leptin on acute inflammatory cascade and metabolic response during hepatic ischemia-reperfusion. This will benefit patients by improving risk-stratification of candidates for hepatic surgery and possibly lead to preventive therapies for ischemia-reperfusion injury.
Research Interests
Inflammatory response to injuryIschemia reperfusion injury
Liver transplantation
Metabolomics
Organ donation
Renal and hepatic injury during surgery
Intensive Insulin Therapy in Deceased Donors-to improve renal allograft function and transplanted allograft outcomes
View Research Profile at UCSF Clinical & Translational Science Institute
Publications
- Therapeutic Hypothermia in Low-Risk Nonpumped Brain-Dead Kidney Donors: A Randomized Clinical Trial.| | PubMed
- International Liver Transplantation Society Global Census: First Look at Pediatric Liver Transplantation Activity Around the World.| | PubMed
- Lactate concentration at the end of liver transplant: Early predictor of graft function or just one piece of the puzzle?| | PubMed
- Hypothermia or Machine Perfusion in Kidney Donors.| | PubMed
- Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference.| | PubMed
- Perioperative mortality in liver transplantation before and after the implementation of the organ allocation policy Share 35.| | PubMed
- Advantages and Limitations of Clinical Scores for Donation After Circulatory Death Liver Transplantation.| | PubMed
- Expedited evaluation for liver transplantation: A critical look at processes and outcomes.| | PubMed
- Organ donor management goals and delayed graft function in adult kidney transplant recipients.| | PubMed
- Perioperative Normal Saline Administration and Delayed Graft Function in Patients Undergoing Kidney Transplantation: A Retrospective Cohort Study.| | PubMed